CSPM EDP Sciences logo
Access to submission and peer review system
Search
Menu
All issues Volume 2 (2021) Vis Cancer Med, 2 (2021) 5 References
Open Access
Issue
Vis Cancer Med
Volume 2, 2021
Article Number 5
Number of page(s) 6
DOI https://doi.org/10.1051/vcm/2021002
Published online 20 August 2021
  1. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. Journal of the National Cancer Institute. 2000;92(14):1143–1150. [Google Scholar]
  2. Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (London, England). 2011;378(9804):1707–1716. [Google Scholar]
  3. Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. The Lancet Oncology. 2008;9(4):331–341. [Google Scholar]
  4. Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (London, England). 2008;371(9618):1098–1107. [Google Scholar]
  5. Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. The Lancet Oncology. 2006;7(6):467–471. [Google Scholar]
  6. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. Journal of the National Cancer Institute. 2002;94(15):1143–1150. [Google Scholar]
  7. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. The Lancet Oncology. 2013;14(11):1086–1094. [Google Scholar]
  8. Wang SL, Fang H, Hu C, et al. Hypofractionated versus conventional fractionated radiotherapy after breast-conserving surgery in the modern treatment era: A multicenter, randomized controlled trial from China. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2020;38(31):3604–3614. [Google Scholar]
  9. Shaitelman SF, Lei X, Thompson A, et al. Three-year outcomes with hypofractionated versus conventionally fractionated whole-breast irradiation: results of a randomized, noninferiority clinical trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2018;36(35):Jco1800317. [Google Scholar]
  10. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. The New England Journal of Medicine. 2013;368(11):987–998. [Google Scholar]
  11. Taylor C, Correa C, Duane FK, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2017;35(15):1641–1649. [Google Scholar]
  12. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1994;12(3):447–453. [Google Scholar]
  13. Berrington de Gonzalez A, Curtis RE, Kry SF, et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. The Lancet Oncology. 2011;12(4):353–360. [Google Scholar]
  14. Grantzau T, Mellemkjær L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2013;106(1):42–49. [Google Scholar]
  15. Kammerer E, Guevelou JL, Chaikh A, et al. Proton therapy for locally advanced breast cancer: A systematic review of the literature. Cancer Treatment Reviews. 2018;63:19–27. [Google Scholar]
  16. Bradley JA, Dagan R, Ho MW, et al. Initial report of a prospective dosimetric and clinical feasibility trial demonstrates the potential of protons to increase the therapeutic ratio in breast cancer compared with photons. International Journal of Radiation Oncology, Biology, Physics. 2016;95(1):411–421. [Google Scholar]
  17. Patel SA, Lu HM, Nyamwanda JA, et al. Postmastectomy radiation therapy technique and cardiopulmonary sparing: A dosimetric comparative analysis between photons and protons with free breathing versus deep inspiration breath hold. Practical Radiation Oncology. 2017;7(6):e377–e384. [Google Scholar]
  18. RTOG. Breast Cancer Atlas for Radiation Therapy Planning: Consensus Definitions. 2017. [Google Scholar]
  19. Hodapp N, Prescribing, recording, and reporting photon-beam Intensity-Modulated Radiation Therapy (IMRT). Journal of the ICRU. 2010;10(1):NP. [Google Scholar]
  20. Mast ME, Vredeveld EJ, Credoe HM, et al. Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients. Breast Cancer Research and Treatment. 2014;148(1):33–39. [Google Scholar]
  21. Sun T, Lin X, Tong Y, et al. Heart and cardiac substructure dose sparing in synchronous bilateral breast radiotherapy: a dosimetric study of proton and photon radiation therapy. Frontiers in Oncology. 2019;9:1456. [Google Scholar]
  22. MacDonald SM, Patel SA, Hickey S, et al. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. International Journal of Radiation Oncology, Biology, Physics. 2013;86(3):484–490. [Google Scholar]
  23. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England). 2005;366(9503):2087–2106. [Google Scholar]
  24. Duma MN, Molls M, Trott KR.From heart to heart for breast cancer patients – cardiovascular toxicities in breast cancer radiotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]. 2014;190(1):5–7. [Google Scholar]
  25. Wu GX, Nelson RA, Kim JY, et al. Non-small cell lung cancer as a second primary among patients with previous malignancy: Who is at risk? Clinical Lung Cancer. 2017;18(5):543–550.e3. [Google Scholar]
  26. Ares C, Khan S, Macartain AM, et al. Postoperative proton radiotherapy for localized and locoregional breast cancer: Potential for clinically relevant improvements? International Journal of Radiation Oncology, Biology, Physics. 2010;76(3):685–697. [Google Scholar]
  27. Depuydt T. Proton therapy technology evolution in the clinic: impact on radiation protection. Annals of the ICRP. 2018;47(3–4):177–186. [Google Scholar]
  28. Chang JY, Zhang X, Knopf A, et al. Consensus Guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and lymphoma subcommittee. International Journal of Radiation Oncology, Biology, Physics. 2017;99(1):41–50. [Google Scholar]
  29. Gueulette J, Blattmann H, Pedroni E, et al. Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. Influence of motion. International Journal of Radiation Oncology, Biology, Physics. 2005;62(3):838–845. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.